BNP PARIBAS FINANCIAL MARKETS - AKERO THERAPEUTICS INC ownership

AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 95 filers reported holding AKERO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of AKERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,010,572
+81.8%
59,521
+67.8%
0.00%
+100.0%
Q2 2023$1,656,281
-32.9%
35,474
-45.0%
0.00%
-33.3%
Q1 2023$2,468,420
+19.3%
64,517
+70.9%
0.00%0.0%
Q4 2022$2,069,248
-99.6%
37,760
+158.3%
0.00%
+200.0%
Q3 2022$497,743,000
+135.2%
14,618
-34.7%
0.00%
Q2 2022$211,661,000
+126.7%
22,398
+240.3%
0.00%
Q1 2022$93,384,000
-22.5%
6,581
+15.5%
0.00%
Q4 2021$120,470,000
+12.3%
5,696
+18.7%
0.00%
Q3 2021$107,235,000
+359.3%
4,798
+409.9%
0.00%
Q2 2021$23,346,000
-53.3%
941
-45.4%
0.00%
Q1 2021$49,955,000
+45.7%
1,722
+29.6%
0.00%
Q4 2020$34,288,000
-63.9%
1,329
-56.9%
0.00%
Q3 2020$94,864,000
+785.3%
3,081
+616.5%
0.00%
Q2 2020$10,716,000
-79.6%
430
-82.6%
0.00%
Q1 2020$52,470,000
+320.6%
2,475
+340.4%
0.00%
Q4 2019$12,474,000
-9.2%
562
-7.0%
0.00%
Q3 2019$13,741,0006040.00%
Other shareholders
AKERO THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Skorpios Trust 3,271,829$125,180,17850.58%
COMMODORE CAPITAL LP 790,000$30,225,4004.60%
Redmile Group, LLC 2,044,389$78,218,3233.39%
SILVERARC CAPITAL MANAGEMENT, LLC 202,561$7,749,9843.20%
Ghost Tree Capital, LLC 275,000$10,522,0003.11%
Avidity Partners Management LP 2,447,000$93,622,2203.11%
Atlas Venture Life Science Advisors, LLC 594,251$22,736,0433.08%
Logos Global Management LP 400,000$15,304,0002.19%
Yiheng Capital Management, L.P. 1,125,791$43,072,7641.70%
Boxer Capital, LLC 831,495$31,8131.56%
View complete list of AKERO THERAPEUTICS INC shareholders